methyl 3-cyanocinnamate | 52116-81-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: methyl 3-cyanocinnamate
• 英文别名: methyl 3-(3-cyanophenyl) acrylate；Methyl 3-(3-cyanophenyl)prop-2-enoate
• CAS: 52116-81-1
• 化学式: C₁₁H₉NO₂
• 分子量: 187.198
• InChiKey: BQJYULBYGRTLPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  50.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2926909090
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  methyl 3-cyanocinnamate 在 Lindlar's catalyst sodium hydroxide 、 氢气 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 为溶剂， 25.0 ℃ 、310.27 kPa 条件下， 反应 10.0h， 生成 3-氰基苯丙酸
  参考文献：
  名称：

  Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

  摘要：

  The discovery and some of the basic structure-activity relationships of a series of novel nonpeptide inhibitors of blood coagulation Factor Xa is described. These inhibitors are functionalized p-alanines, exemplified by 2a. Docking experiments placing 2a in the active site of Factor Xa implied that the Most expeditious route to enhancing in vitro potency was to modify the group occupying the S3 site of the enzyme. Increasing the hydrophobic contacts between the inhibitor and the enzyme in this region led to 8, which has served as the prototype for this series. In addition, an enantioselective synthesis of these substituted p-alanines was also developed.

  DOI：

  10.1021/jm970482y
• 作为产物：
  描述：

  3-氰基苯甲醛 在 哌啶 作用下， 以 吡啶 为溶剂， 生成 methyl 3-cyanocinnamate
  参考文献：
  名称：

  Wagner; Garbe; Richter, Pharmazie, 1973, vol. 28, # 11, p. 724 - 729

  摘要：

  DOI：

文献信息

• Manganese-catalyzed homogeneous hydrogenation of ketones and conjugate reduction of α,β-unsaturated carboxylic acid derivatives: A chemoselective, robust, and phosphine-free in situ-protocol
  作者：Thomas Vielhaber、Christoph Topf

  DOI：10.1016/j.apcata.2021.118280

  日期：2021.8

  glove-box-free catalytic protocol for the manganese-catalyzed hydrogenation of ketones and conjugated CCbonds of esters and nitriles. The respective catalyst is readily assembled in situ from the privileged [Mn(CO)5Br] precursor and cheap 2-picolylamine. The catalytic transformations were performed in the presence of t-BuOK whereby the corresponding hydrogenation products were obtained in good to excellent yields

  我们传达了一种用户友好且无需手套箱的催化协议，用于酮和酯和腈的共轭 C C键的锰催化氢化。相应的催化剂很容易由特权 [Mn(CO) 5 Br] 前体和廉价的 2-吡啶甲胺原位组装。催化转化在t- BuOK存在下进行，从而以良好至极好的收率获得相应的氢化产物。所描述的系统提供了对仲醇和饱和酯的快速和原子效率的访问，避免了使用氧敏感和昂贵的基于膦的配体。
• Enantioselective Synthesis of Pyroglutamic Acid Esters from Glycinate via Carbonyl Catalysis
  作者：Jiguo Ma、Qinghai Zhou、Guanshui Song、Yongchang Song、Guoqing Zhao、Kuiling Ding、Baoguo Zhao

  DOI：10.1002/anie.202017306

  日期：2021.5.3

  Direct α‐functionalization of NH2‐free glycinates with relatively weak electrophiles such as α,β‐unsaturated esters still remains a big challenge in organic synthesis. With chiral pyridoxal 5 d as a carbonyl catalyst, direct asymmetric conjugated addition at the α‐C of glycinate 1 a with α,β‐unsaturated esters 2 has been successfully realized, to produce various chiral pyroglutamic acid esters 4 in 14–96 %

  用相对较弱的亲电试剂（例如，α，β-不饱和酯）将不含NH 2的甘氨酸直接进行α-官能化仍然是有机合成中的一大挑战。以手性吡ido醛5 d作为羰基催化剂，已成功实现在甘氨酸1a的α-C与α，β-不饱和酯2的直接不对称共轭加成反应，以14-96％的收率生产各种手性焦谷氨酸酯4原位内酰胺化后具有81–97％ee的物质。该反式与顺非对映异构体可以通过色谱法同时获得，并且可以很容易地通过叔丁基去除和随后的Barton转化为手性4取代的吡咯烷-2-酮，例如具有相同绝对构型的阿兹海默氏药物Rolipram（11）。脱羧。
• Development of a Cross‐Conjugated Vinylogous [4+2] Anionic Annulation and Application to the Total Synthesis of Natural Antibiotic (±)‐ABX
  作者：Jing‐Kai Huang、Kak‐Shan Shia

  DOI：10.1002/anie.201914657

  日期：2020.4.16

  vinylogous [4+2] anionic annulation has been newly developed, the cascade process of which has a high preference for regiochemical control and chemoselectivity, giving rise to exclusively Michael-type adducts in moderate to high yields (up to 94 %, 35 examples). By making use of this approach as a key operation, the first total synthesis of natural antibiotic ABX, in racemic form, has been successfully

  交叉共轭的乙烯基[4 + 2]阴离子环化技术已经得到了新的发展，其级联工艺对区域化学控制和化学选择性具有很高的偏爱，从而以中等至高的收率（高达94％的产率）产生了唯一的迈克尔型加合物。 （35个示例）。通过将该方法用作关键操作，已成功地以简明的7个步骤成功完成了外消旋形式的天然抗生素ABX的首次全合成，总收率约为20％。
• Flexible, dicationic imidazolium salts for<i>in situ</i>application in palladium-catalysed Mizoroki-Heck coupling of acrylates under aerobic conditions
  作者：Marilyn Daisy Milton、Parul Garg

  DOI：10.1002/aoc.3503

  日期：2016.9

  incorporating the features of both bidentate chelating O,O ligand and carbene, shows the maximum catalytic activity. A variety of aryl and heteroaryl methyl and ethyl cinnamates were synthesized using these imidazolium salts as preligands. In addition, NMR studies confirm in situ generation of normal N‐heterocyclic carbenes from the C‐2 position of imidazol‐2‐ylidene ring. The mercury poisoning test was also

  新的不对称N，N的合成，表征及原位催化性能描述了在好氧条件下丙烯酸酯与芳基溴化物在咪唑罗基-赫克偶联过程中基于二氮杂咪唑的二元盐。合成了一系列具有可变的空间和电子特性的柔性二羧酸盐，收率良好。使用光谱技术可以很好地表征所有盐。X射线衍射分析具有相同的双主链和不同的抗衡阴离子的两种盐表明，配体采用两种不同的构象，这些构象受阴离子的性质影响。因此，配体由于其柔性性质而能够根据环境变化而改变其构象。发现所有合成的咪唑鎓盐均在原位具有活性有氧条件下钯催化的米佐罗基-赫克偶联。在这些盐中，结合了双齿螯合O，O配体和卡宾的特征的羟基官能化咪唑鎓盐显示出最大的催化活性。使用这些咪唑鎓盐作为预配体合成了各种肉桂酸的芳基和杂芳基甲基和乙基酯。此外，NMR研究证实原位生成正常N咪唑-2-亚烷基环的C-2位的杂环卡宾。还进行了汞中毒测试，以确定具有催化活性的钯物质的性质。有氧条件，低催化负载量（0.5 mol％
• Cyclopropyl Amide Derivatives
  申请人：Griffin Andrew

  公开号：US20100216812A1

  公开（公告）日：2010-08-26

  Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.

  本文披露了至少一种环丙基酰胺衍生物，至少一种包含本文披露的至少一种环丙基酰胺衍生物的药物组合物，以及至少一种使用本文披露的至少一种环丙基酰胺衍生物治疗至少一种与组织胺H3受体相关疾病的方法。